1. Home
  2. Analysis
  3. Sutab
  4. Gabapentin

Sutab and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sutab (magnesium sulfate; potassium chloride; sodium sulfate) and Gabapentin (gabapentin). Common drug interactions include paraesthesia among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Sutab and Gabapentin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Sutab?

Sutab has active ingredients of magnesium sulfate; potassium chloride; sodium sulfate. eHealthMe is studying from 1,177 Sutab users. Check the latest studies of Sutab.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

On Jul, 20, 2026

23 people who take Sutab and Gabapentin together, and have interactions are studied.

Sutab and Gabapentin drug interactions.

What are the common drug interactions of Sutab and Gabapentin, by gender? *:

female:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Abdominal discomfort
  3. Abdominal distension
  4. Abdominal pain
  5. Abdominal pain upper
  6. Blood glucose decreased
  7. Cardiovascular disorder (heart diseases)
  8. Hyperglycaemia (high blood sugar)
  9. Hypersensitivity
  10. Hypokalaemia (low potassium)

male:

  1. Vomiting
  2. Kidney infection
  3. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  4. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Sutab and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hot flush (sudden feelings of heat)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Vomiting

50-59:

  1. Blood glucose decreased
  2. Burning sensation
  3. Dizziness
  4. Hypersensitivity
  5. Pruritus (severe itching of the skin)

60+:

  1. Vomiting
  2. Nausea (feeling of having an urge to vomit)
  3. Hyperglycaemia (high blood sugar)
  4. Hypokalaemia (low potassium)
  5. Abdominal distension
  6. Abdominal pain lower
  7. Abdominal pain upper
  8. Anxiety
  9. Blood pressure increased
  10. Bowel movement irregularity

What are the existing conditions these people have? *

  1. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 13.04%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 8.70%
  3. Multiple Myeloma (cancer of the plasma cells): 2 people, 8.70%
  4. Colon Cancer: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Sutab and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sutab and Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sutab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sutab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on magnesium sulfate; potassium chloride; sodium sulfate and gabapentin (the active ingredients of Sutab and Gabapentin, respectively), and Sutab and Gabapentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.